Clinical Trial Update: The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic Cigarette [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of zonisamide and bupropion for smoking cessation (switching to an electronic cigarette) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Zonisamide (zonisamide)
• bupropion (bupropion)

Snippet

Sponsor: Rose Research Center, LLC | Conditions: Smoking Cessation | Phase 3 | Status: COMPLETED